Importantly, the CD27+CD28+ phenotype was more frequently—though variable for each patient with NSCLC—observed in tilTemra, and its presence was largely dependent on a persistent low-grade TCR signal, implying a close relationship with the immunogenicity of tumor antigens. The gene discussed is CD28; the disease is non-small cell lung carcinoma.